Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-12 4:13 pm Sale | 13G | STEMLINE THERAPEUTICS INC STML | EVENTIDE ASSET MANAGEMENT LLC | 0 0% | -4,160,608 (Position Closed) | View |
| 2020-05-13 2:43 pm Purchase | 13D | STEMLINE THERAPEUTICS INC STML | A. Menarini - Industrie Farmaceutiche Riunite - S.r.l. | 2,726,350 5.2% | 2,726,350 (New Position) | View |
| 2020-02-14 9:34 pm Purchase | 13G | STEMLINE THERAPEUTICS INC STML | Bergstein Ivan | 3,633,909 7.1% | 158,184 (+4.55%) | View |
| 2020-02-14 08:53 am Purchase | 13G | STEMLINE THERAPEUTICS INC STML | Rubric Capital Management LP | 3,500,000 6.98% | 3,500,000 (New Position) | View |
| 2020-02-12 4:13 pm Purchase | 13G | STEMLINE THERAPEUTICS INC STML | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,210,000 6.4% | 1,012,908 (+46.10%) | View |
| 2020-02-12 12:58 pm Purchase | 13G | STEMLINE THERAPEUTICS INC STML | MANULIFE FINANCIAL CORP | 2,559,069 11% | 2,559,069 (New Position) | View |
| 2020-02-06 09:10 am Purchase | 13G | STEMLINE THERAPEUTICS INC STML | BlackRock Inc. BLK | 3,715,648 7.4% | 1,650,409 (+79.91%) | View |
| 2020-02-04 3:36 pm Purchase | 13G | STEMLINE THERAPEUTICS INC STML | EVENTIDE ASSET MANAGEMENT LLC | 4,160,608 8.3% | 4,160,608 (New Position) | View |
| 2019-02-22 4:38 pm Purchase | 13G | STEMLINE THERAPEUTICS INC STML | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,197,092 5.42% | 1,487,078 (+209.44%) | View |
| 2019-02-14 10:17 am Purchase | 13G | STEMLINE THERAPEUTICS INC STML | Polar Capital LLP | 2,902,666 9.13% | 2,902,666 (New Position) | View |
| 2019-02-14 07:49 am Sale | 13G | STEMLINE THERAPEUTICS INC STML | Consonance Capital Management LP | 1,155,793 3.63% | -1,193,999 (-50.81%) | View |
| 2019-02-13 1:49 pm Sale | 13G | STEMLINE THERAPEUTICS INC STML | ADAGE CAPITAL PARTNERS GP L.L.C. | 710,014 2.23% | -724,900 (-50.52%) | View |
| 2019-02-13 12:04 pm Sale | 13G | STEMLINE THERAPEUTICS INC STML | FMR LLC | 1,446,798 4.549% | -156,372 (-9.75%) | View |
| 2019-02-08 8:58 pm Purchase | 13G | STEMLINE THERAPEUTICS INC STML | Bergstein Ivan | 3,475,725 8.1% | 485,226 (+16.23%) | View |
| 2019-02-07 6:11 pm Purchase | 13G | STEMLINE THERAPEUTICS INC STML | BlackRock Inc. BLK | 2,065,239 6.5% | 677,456 (+48.82%) | View |
| 2018-08-10 11:16 am Sale | 13G | STEMLINE THERAPEUTICS INC STML | FMR LLC | 1,603,170 5.295% | -1,531,146 (-48.85%) | View |